Novo Nordisk

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments.

CEO

Maziar Mike Doustdar

CEOMaziar Mike Doustdar

Employees

68,794

Employees68,794

Headquarters

Bagsværd, Capital Region

HeadquartersBagsværd, Capital Region

Founded

1923

Founded1923

Employees

68,794

Employees68,794

NVO Key Statistics

Market cap

169.29B

Market cap169.29B

Price-Earnings ratio

9.34

Price-Earnings ratio9.34

Dividend yield

3.22%

Dividend yield3.22%

Average volume

13.32M

Average volume13.32M

High today

$38.19

High today$38.19

Low today

$38.07

Low today$38.07

Open price

$37.77

Open price$37.77

Volume

221.71K

Volume221.71K

52 Week high

$64.16

52 Week high$64.16

52 Week low

$35.12

52 Week low$35.12

NVO News

The Motley Fool 10h

UBS Called Novo Nordisk a 'Value Trap.' Here's the Other Side of That Argument.

UBS analyst Michael Yee clearly preferred Eli Lilly (LLY -1.61%) over Novo Nordisk (NVO -0.21%) in a recent discussion with CNBC. Describing Eli Lilly as a grow...

TipRanks 20h

Novo Nordisk Wraps Up Real World Joint Health Study for Esperoct in Haemophilia A

Novo Nordisk (NVO) announced an update on their ongoing clinical study. The Novo Nordisk A/S observational study, officially titled “Non-Interventional Study o...

TipRanks 3d

Novo Nordisk Probes Patient Priorities in German Hemophilia A Study

Novo Nordisk (NVO) announced an update on their ongoing clinical study. Novo Nordisk Tests What Matters Most to Hemophilia A Patients in Germany. This study, t...

Analyst ratings

50%

of 6 ratings

Buy

16.7%

Hold

50%

Sell

33.3%

More NVO News

TipRanks 3d

Novo Nordisk Expands Treasury Stake as DKK 15bn Buyback Nears DKK 10bn Mark

Novo Nordisk ( (NVO) ) has shared an update. Novo Nordisk has continued executing its DKK 15 billion, 12‑month share repurchase programme launched on 4 Februar...

Zacks 3d

Is Most-Watched Stock Novo Nordisk A/S Worth Betting on Now?

Novo Nordisk (NVO Quick QuoteNVO - Free Report) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some...

TipRanks 4d

Cboe data shows mixed options sentiment in Novo Nordisk with shares down 0.47%

Cboe data shows mixed options sentiment in Novo Nordisk (NVO), with shares down 18c near $37.15. Options volume relatively light with 24k contracts traded and c...

The Motley Fool 7d

Novo Nordisk Strikes Nearly $4 Billion in 2 Deals. Here's What That Means for Investors

Novo Nordisk (NVO -0.21%) is looking to maintain its position in the weight-loss market and one-up its most important competitor, Eli Lilly (LLY -0.61%). To tha...

TipRanks 7d

Novo Nordisk Tests Zenagamtide Dosing to Sharpen Its Obesity Drug Pipeline

Novo Nordisk (NVO) announced an update on their ongoing clinical study. The study Investigating the Effect of Post-dose Meal Timings and Water Volume at Dosing...

The Motley Fool 7d

Novo Nordisk vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?

As the global healthcare landscape shifts toward weight-loss treatments and chronic care, investors are weighing two giants. Should you invest in Novo Nordisk A...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.